Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management.
Content based on an online CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York
Senior Scientific Director
Executive Vice President
Scientific Director
This program has been made available online.
Dr. Roger Paredes reviews safety and efficacy data on COVID-19 vaccines and considerations for vaccine rollout from Clinical Care Options (CCO)
Vikramjit Mukherjee, MD, provides a brief update on COVID-19 and answers clinician questions in the CCO Infectious Disease podcast
Review frequently asked questions and answers from expert CCO faculty on rapidly evolving data on COVID-19 vaccines and immunity
In this concise presentation, Professor Yee-Sin Leo reviews COVID-19 vaccine hesitancy data, and the factors that impact vaccine hesitancy.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.